Article

Safilo Group, Hugo Boss ink licensing ageement

Padua, Italy?Two of Europe's fashion trendsetters, Safilo Group, a leader in high-end eyewear, and Hugo Boss, Metzingen, Germany, one of the leading international groups in the high-fashion market, have signed a license agreement in force through Dec. 31, 2013 for the design, production, and worldwide distribution of Boss and Hugo eyewear collections.

Padua, Italy-Two of Europe's fashion trendsetters, Safilo Group, a leader in high-end eyewear, and Hugo Boss, Metzingen, Germany, one of the leading international groups in the high-fashion market, have signed a license agreement in force through Dec. 31, 2013 for the design, production, and worldwide distribution of Boss and Hugo eyewear collections.

"With Safilo Group, Hugo Boss has found a strong license partner in the eyewear sector," said Bruno Sälzer, chief executive officer, Hugo Boss. "We are very pleased about this cooperation and are looking forward to a successful future together."

"We are particularly happy to partner with one of the leading brands in the fashion industry. Our positions as global leaders in our respective sectors, along with our combined experience and expertise in design, quality, and distribution, will ensure that this partnership is a success," said Vittorio Tabacchi, chairman, Safilo Group.

Hugo Boss and Safilo Group will ensure the smooth transition of Boss and Hugo eyewear collections from current licensor Charmant to Safilo Group.

Related Videos
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
 John Bladen, MBBS, BSc, MRCS, PGCert, PhD, FRCOphth, consultant ophthalmologist and oculoplastic surgeon, King's College Hospital NHS Foundation Trust, London, UK, speaks with Ophthalmology Times Europe's® Caroline Richards
rande, CFP, and John S. Grande, CFP, of Grande Financial Services, continue their discussion with Ophthalmology Times®' Sheryl Stevenson
© 2024 MJH Life Sciences

All rights reserved.